Programme on Tuesday, 2nd October 2018

7.30–8.15
Meet the Professor (Parallel Sessions)
7.30–8.15
Carrick 3
EBV-associated lesions: Management of diagnostic problems
E. S. Jaffe
7.30–8.15
Harris 1
Moving beyond the primary diagnosis: challenges in progressed and “treated” haematologic neoplasms
R. Hasserjian
7.30–8.15
Carrick 1 & 2
From clinic to molecular: integration of all modalities in daily lymphoma diagnostics
D. de Jong
7.30–8.15
Harris 2
A day in the life of a haematopathologist – challenges and solutions
S. H. Swerdlow
8.30-9.00
Genetic features of primary CNS Iymphoma (Keynote Lecture)
B. Chapuy
9.00-10.30
Lymphoma Symposium (Session 4)

Chairs: B. Sander, D. Gratzinger
9.00-9.30 Topic Lecture: Lymphoproliferative disorders in immune privileged sites
other than CNS and testis
D. de Jong
9.30-9.45 LYS-O-4-1
Gene Expression Profile distinguishes Breast Implant-Associated Anaplastic
Large Cell lymphoma from other Peripheral T-cell Lymphomas
A. Di Napoli
9.45-10.00 LYS-O-4-2
The role of PD-1 and PD-L1 in T-cell immune suppression in patients
with primary testicular diffuse large B-cell lymphoma (PT-DLBCL)
M. R. Ambrosio
10.00-10.15 LYS-O-4-3
Next generation sequencing of vitreoretinal B-cell lymphoma reveals
a mutational landscape similar to primary central nervous system
lymphoma and facilitates diagnosis
I. Bonzheim
10.15-10.30 Poster Review: Poster prize award
E. Sabattini, M. Guenova, S. Rodig
10.30-11.15
Coffee Break, Poster Presentations and Poster Viewing
11.15-13.00
Lymphoma Symposium (Session 5)

Chairs: P. Jansen, S. Song
11.15-11.45 Topic Lecture: The importance of clinical correlation
in cutaneous lymphoma
W. Kempf
11.45-12.00 LYS-O-5-1
Localized low-stage follicular lymphomas exhibit distinct biological/
genetic features
H. Horn
12.00-12.15 LYS-O-5-2
Frequency of potential N-glycosylation sites in t(14;18)-positive
and negative low and high stage follicular lymphoma
E. Leich-Zbat
12.15-12.30 LYS-O-5-3
Reproducibility of MYC protein expression scoring and impact
on the prognosis of aggressive B-cell lymphoma patients
M. R. Ambrosio
12.30-12.45 LYS-O-5-4
Mutations analysis as an aid to separate diffuse large b-cell lymphoma
subgroups according to the cell of origin
A. Mayer
12.45-13.00 LYS-O-5-5
Engagement of RelA, cRel or RelB NF-kB subunit activation impacts
on classification and prognosis of diffuse large B-cell lymphoma
D. Collares
13.00-14.30
Lunch and Satellite Symposium
14.30-15.30
Lymphoma Symposium (Session 6)

Chairs: S. Dojcinov, J. Geyer
14.30-14.45 LYS-O-6-1
THRLBCL immune transcriptomic profile displays high expression
of inhibitory receptors and tolerogenic molecules
V. Tabanelli
14.45-15.00 LYS-O-6-2
JUNB, DUSP2, SGK1, CREBBP and SOCS1 are frequently mutated
in T-cell/histiocyte rich large B-cell lymphoma
S. Hartmann
15.00-15.15 LYS-O-6-3
FBXO11 is a frequently mutated oncosuppressor in Burkitt Lymphoma
C. Pighi
15.15-15.30 LYS-O-6-4
Burkitt-like lymphoma with 11q aberration: A germinal center-derived
lymphoma without ID3-TCF3-CCND3 pathway deregulation
B. Gonzalez-Farre
15.30-16.00
Coffee Break and Poster Viewing
16.00-17.15
David Mason Lecture
16.00-16.15 David Mason Awardee Lecture
16.15-17.15 The role of immunotherapy in solid oncology
J. Haanen
17.15-18.00
General Assembley
20.00-23.00
Networking Dinner
National Museum of Scotland –
please refer to page 7 for further details – tickets required